A phase II trial on radiotherapy for high-risk asymptomatic bone metastases-creating more questions than answers?

Autor: Chan AW; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Simone CB 2nd; Department of Radiation Oncology, New York Proton Center, New York, NY, USA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., van der Velden JM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands., van der Linden Y; Department of Radiotherapy, Leiden University Medical Centre, Leiden, Netherlands; Centre of Expertise in Palliative Care, Leiden University Medical Centre, Leiden, Netherlands., Hoskin P; Mount Vernon Cancer Centre, Northwood, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK., Detsky J; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Choi JI; Department of Radiation Oncology, New York Proton Center, New York, NY, USA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee SF; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, China., Wong HCY; Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, Hong Kong, China., Martin EJ; Department of Medicine, University of California, Los Angeles, CA, USA., Raman S; Department of Radiation Oncology, Princess Margaret Cancer Center, Toronto, Canada., Rades D; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany., Willmann J; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rembielak A; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Clinical Oncology, Christie NHS Foundation Trust, Manchester, UK., Kazmierska J; Radiotherapy Department II, Greater Poland Cancer Centre, Poznan, Poland; Electroradiology Department, University of Medical Sciences, Poznan, Poland., Keit ER; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Marta GN; Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Vassiliou V; Department of Radiation Oncology, Bank of Cyprus Oncology Centre, Strovolos, Cyprus., Alcorn S; Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, USA., Bonomo P; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Oldenburger E; Department of Radiation Oncology, University Hospital Leuven, Leuven, Belgium.

Publikováno v: Annals of palliative medicine [Ann Palliat Med] 2024 May; Vol. 13 (3), pp. 733-738. Date of Electronic Publication: 2024 Apr 17.